Acorda Therapeutics® is a biotechnology company whose mission is to develop and market therapies related to the nervous system.
Acorda Therapeutics® was established in March 1995 to develop therapies that restore neurological function to people with spinal cord injury (SCI), multiple sclerosis (MS) and related conditions of the nervous system.